+MOREAbout Us

Biosynergics values quality and efficiency in all of its services. With more than over 100 cases of antibody development services to pharmaceutical businesses a...


Based on its proprietary antibody technology platforms (H3 antibody technology, Synergistic Antibody technology [SynAbTM]), BSI is committed to the development ...

Company News

Biosynergics, Inc. Completes Series A Financing and Company Restructuring. —On October 29, 2017, Biosynergics, Inc., a China-based startup biotech...


New Products

【NEW!】Mouse anti-Human HER2/ErbB2 Monoclonal Antibody

IVD Raw Materials
For further information, please scan the QR code to follow us.
About us|Technology|Therapeutics|Diagnostics|Support|Contact Us
copyright 2015 Biosynergics Inc 苏ICP备13049856号-1